RongHeMD

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Professor, Laboratory Medicine & Pathology, Mayo Medical School

Dr. He is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Rong He is a pathologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. She received her medical degree from Hunan Medical University and has been in practice 17 years. She specializes in hematopathology, molecular genetics, anatomic pathology, and clinical pathology and is experienced in myelodysplasia, leukemia, and bleeding and thrombotic disorders. She is the co-director of the Molecular Hematopathology Lab and has more than 100 publications and over 500 citings.

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematopathology, 2010 - 2011
University of Wisconsin Hospitals and ClinicsResidency, Pathology-Anatomic and Clinical, 2006 - 2010
Hunan Medical UniversityClass of 1994

PubMed

Molecular techniques in haematopathology: what and how?
Gaurav Chatterjee, Rong He, Nikhil Patkar, David Viswanatha, Anton W Langerak
Histopathology. 2025-01-01
1 citations
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis.
Ayalew Tefferi, Saubia Fathima, Ali Khalid A Alsugair, Fnu Aperna, Anuya Natu
American Journal of Hematology. 2024-12-01
Characterisation and prognostic impact Of ZRSR2 mutations in myeloid neoplasms.
Mahmoud Yacout, Bahga Katamesh, Yazan Jabban, Rong He, David Viswanatha
Leukemia. 2024-12-01

Journal Articles

Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid l...
Rong He, Daniel J. Devin1, Zheng Jin Tu, Ming Mai, Dong Chen, Phuong L. Nguyen, Jennifer L. Oliveira, James D. Hoyer, Kaaren K. Reichard, Paul L. Ollila, Aref Al-Kali,..., Modern Pathology, 8/30/2019
Genetic Subtyping of Breast Implant-Associated Anaplastic Large Cell Lymphoma
Andrew L Feldman, Garry S Brody, Rhett P Ketterling, N Nora Bennani, Mark W Clemens, Ellen D McPhail, Christin A Harless, David S Viswanatha, Rong He, Blood

Abstracts/Posters

Phenotypic Correlates and Prognostic Outcomes of TET2 Mutations in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes: A Comprehensive Study of 504...
Rong He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial
Rong He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Comparison of _LEPRA and _LELY Co-Inheritance with a SPTA1 Whole Gene Deletion, a Family Study
Rong He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Spectrum of Abnormalities and Clonal Transformation in Germline RUNX1 Familial Platelet Disorder and a Comparative Analysis with Somatic RUNX1 Mutations in Myeloid Neo...
Rong He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Long Range Sequencing Shows Improved Resolution in the Detection of Beta Globin Cluster Variants
Rong He, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Lectures

Current Status of Clinical Laboratory Testing of Plasma Cell Neoplasms: A Case-Based Approach
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
A Phase II of Combination Daunorubicin and Cytarabine (Ara-c) and Nilotinib (TAsigna) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018